top of page

Daily Updates
Daily biotech and biopharma stock updates including recent catalyst readouts, financial news, and upcoming catalyst events.


Biopharma Daily Stock Updates - 01/25/22
$XBI $91.38 | -0.80% Covid Updates $VALN +6.5% Valneva Advances Booster Phase of Cov-Compare Trial of Its Inactivated COVID-19 Vaccine...
Jan 25, 2022


Biopharma Daily Stock Updates - 01/24/22
$XBI $92.11 | +2.31% Covid Updates $SRNE -7.1% Sorrento Receives Purchase Order for 10 Million Covistix Tests From Its Subsidiary...
Jan 24, 2022


Biopharma Daily Stock Updates - 01/21/22
$XBI $90.03 | -2.1% Covid Updates $GILD +1.0% FDA Approves Veklury® (Remdesivir) for the Treatment of Non-Hospitalized Patients at High...
Jan 22, 2022


Biopharma Daily Stock Updates - 01/20/22
$XBI $91.70 | -1.64% Covid Updates $ Pipeline Updates $PRVB -1.8% Provention Bio Announces Initiation of the Phase 2a PREVAIL-2 Study...
Jan 20, 2022


Biopharma Daily Stock Updates - 01/19/22
$XBI $93.50 | -1.08% Covid Updates $NVAX -6.2% Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for...
Jan 19, 2022


Biopharma Daily Stock Updates - 01/18/22
$XBI $94.52 | -5.94% Covid Updates $SRNE -7.2% Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Clinical Trial...
Jan 18, 2022


Biopharma Daily Stock Updates - 01/14/22
$XBI $100.49 | +2.44% d Covid Updates $RDHL +2.9% RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase...
Jan 14, 2022


Biopharma Daily Stock Updates - 01/13/22
$XBI $98.10 -2.5% Covid Updates $RDHL -1.6% RedHill Biopharma's Oral Opaganib Significantly Improves Viral Clearance in Phase 2/3 Study...
Jan 13, 2022


Biopharma Daily Stock Updates - 01/12/22
$XBI $100.60 -3.2% Covid Updates $OCGN +0.24 COVAXIN™ (BBV152) Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2...
Jan 12, 2022


Biopharma Daily Stock Updates - 01/11/22
$XBI $103.89 0.73% % Covid Updates $TNXP +1.7% Tonix Pharmaceuticals Initiates Enrollment in Clinical Trial of TNX-2100, a Diagnostic...
Jan 11, 2022


Biopharma Daily Stock Updates - 01/10/22
$XBI $103.14 +0.2% % Covid Updates $NVAX +6.5% Novavax and Serum Institute of India File for Emergency Use Authorization of Novavax'...
Jan 10, 2022


Biopharma Daily Stock Updates - 01/07/22
$XBI $102.99 | -2.1% % Pipeline Updates $IOVA +1.4% Iovance Biotherapeutics to Present Data on Tumor-Infiltrating Lymphocyte (TIL) Cell...
Jan 7, 2022


Biopharma Daily Stock Updates - 01/06/22
$XBI $105.20 -0.03% % Covid Updates $COCP -3.1% Cocrystal Pharma Receives FDA Guidance to Advance Clinical Development of its COVID-19...
Jan 6, 2022


Biopharma Daily Stock Updates - 01/05/22
$XBI $105.23 -5.50% % Covid Updates $NRXP +3.0% NRx Pharmaceuticals Submits Emergency Use Authorization Application to US Food and Drug...
Jan 5, 2022


Biopharma Daily Stock Updates - 01/03/22
$XBI $111.36 -3.53% % Covid Updates $GRTS -42.4% Gritstone Announces Positive Clinical Results from First Cohort of a Phase 1 Study...
Jan 4, 2022


Biopharma Daily Stock Updates - 01/03/22
$XBI $115.44 +3.11% % Covid Updates $MRNA -7.5% Moderna Announces Supply Agreement with South Korea for Additional 20 Million Doses of...
Jan 3, 2022


Biopharma Daily Stock Updates - 12/31/21
$XBI $111.96 | -1.13%% Covid Updates $VIR Vir Biotechnology Announces New Research Describing the Structural Basis of SARS-CoV-2 Omicron...
Dec 31, 2021


Biopharma Daily Stock Updates - 12/30/21
$XBI $113.24 +0.44%% Covid Updates $OCGN +10.3% Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From...
Dec 30, 2021


Biopharma Daily Stock Updates - 12/28/21
$XBI $113.21 -1.7%% Covid Updates $DVAX -1.3% COVID-19 Vaccine Developed by Biological E Using Dynavax's CpG 1018 Adjuvant Receives India...
Dec 28, 2021


Biopharma Daily Stock Updates - 12/27/21
$XBI $115.17 -2.6%% Covid Updates $MRNA -1.2% Moderna Announces Switzerland Exercises its Option to Purchase Seven Million Additional...
Dec 27, 2021
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page
